165 related articles for article (PubMed ID: 6254698)
1. Evaluation of the three hour metyrapone test in adults.
Best JD; Alford FP; Donald RA
Clin Endocrinol (Oxf); 1980 Jul; 13(1):69-76. PubMed ID: 6254698
[TBL] [Abstract][Full Text] [Related]
2. Investigation of the hypothalamo-pituitary-adrenal axis (HPA) by 1 microg ACTH test and metyrapone test in patients with primary fibromyalgia syndrome.
Calis M; Gökçe C; Ates F; Ulker S; Izgi HB; Demir H; Kirnap M; Sofuoglu S; Durak AC; Tutus A; Kelestimur F
J Endocrinol Invest; 2004 Jan; 27(1):42-6. PubMed ID: 15053242
[TBL] [Abstract][Full Text] [Related]
3. The overnight single-dose metyrapone test is a simple and reliable index of the hypothalamic-pituitary-adrenal axis.
Fiad TM; Kirby JM; Cunningham SK; McKenna TJ
Clin Endocrinol (Oxf); 1994 May; 40(5):603-9. PubMed ID: 8013141
[TBL] [Abstract][Full Text] [Related]
4. Combined stimulation of adrenocorticotropin and compound-S by single dose metyrapone test as an outpatient procedure to assess hypothalamic-pituitary-adrenal function.
Berneis K; Staub JJ; Gessler A; Meier C; Girard J; Müller B
J Clin Endocrinol Metab; 2002 Dec; 87(12):5470-5. PubMed ID: 12466339
[TBL] [Abstract][Full Text] [Related]
5. The low dose ACTH stimulation test is less sensitive than the overnight metyrapone test for the diagnosis of secondary hypoadrenalism.
Soule S; Van Zyl Smit C; Parolis G; Attenborough S; Peter D; Kinvig S; Kinvig T; Coetzer E
Clin Endocrinol (Oxf); 2000 Aug; 53(2):221-7. PubMed ID: 10931104
[TBL] [Abstract][Full Text] [Related]
6. The insulin hypoglycaemia and overnight metyrapone tests in the assessment of the hypothalamic-pituitary-adrenal axis following pituitary surgery.
Courtney CH; McAllister AS; McCance DR; Hadden DR; Leslie H; Sheridan B; Atkinson AB
Clin Endocrinol (Oxf); 2000 Sep; 53(3):309-12. PubMed ID: 10971447
[TBL] [Abstract][Full Text] [Related]
7. Mineralocorticoid receptor function in posttraumatic stress disorder after pretreatment with metyrapone.
Otte C; Muhtz C; Daneshkhah S; Yassouridis A; Kiefer F; Wiedemann K; Kellner M
Biol Psychiatry; 2006 Oct; 60(7):784-7. PubMed ID: 16566900
[TBL] [Abstract][Full Text] [Related]
8. Improved single-dose metyrapone test.
Dickstein G; Barzilai D
Isr J Med Sci; 1980 May; 16(5):365-9. PubMed ID: 6249771
[TBL] [Abstract][Full Text] [Related]
9. Plasma 11-deoxycortisol, androstenedione, testosterone and ACTH in comparison with the urinary excretion of tetrahydro-11-deoxycortisol as indices of the pituitary-adrenal response to oral metyrapone.
de Lange WE; Sluiter WJ; Pratt JJ; Doorenbos H
Acta Endocrinol (Copenh); 1980 Apr; 93(4):488-94. PubMed ID: 6247869
[TBL] [Abstract][Full Text] [Related]
10. Hypothalamic-pituitary-adrenal function in extrinsic asthma.
Morrish DW; Sproule BJ; Aaron TH; Outhet D; Crockford PM
Chest; 1979 Feb; 75(2):161-6. PubMed ID: 217570
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the adrenal responses to hypoglycemia, metyrapone and ACTH.
Nelson JC; Tindall DJ
Am J Med Sci; 1978; 275(2):165-72. PubMed ID: 208417
[TBL] [Abstract][Full Text] [Related]
12. Hypothalamic-pituitary-adrenal axis interaction with prostaglandins.
Thorén M; Stenfors C; Apéria B; Mathé AA
Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(3):319-26. PubMed ID: 2359842
[TBL] [Abstract][Full Text] [Related]
13. Reliability of hormonal levels for assessing the hypothalamic-pituitary-adrenocortical system in clinical pharmacology.
Coste J; Strauch G; Letrait M; Bertagna X
Br J Clin Pharmacol; 1994 Nov; 38(5):474-9. PubMed ID: 7893592
[TBL] [Abstract][Full Text] [Related]
14. Effect of altered thyroid hormone levels on hypothalamic-pituitary-adrenal function.
Kamilaris TC; DeBold CR; Pavlou SN; Island DP; Hoursanidis A; Orth DN
J Clin Endocrinol Metab; 1987 Nov; 65(5):994-9. PubMed ID: 3499449
[TBL] [Abstract][Full Text] [Related]
15. The discrepancy between plasma 11-deoxycortisol and ACTH concentrations in a single dose metyrapone test in normal men.
Matsuki M; Nishida S; Horino M; Tenku A; Oyama H
Acta Endocrinol (Copenh); 1982 Sep; 101(1):62-5. PubMed ID: 6289591
[TBL] [Abstract][Full Text] [Related]
16. Effects of metyrapone on hypothalamic-pituitary-adrenal axis and sleep in women with post-traumatic stress disorder.
Otte C; Lenoci M; Metzler T; Yehuda R; Marmar CR; Neylan TC
Biol Psychiatry; 2007 Apr; 61(8):952-6. PubMed ID: 17336940
[TBL] [Abstract][Full Text] [Related]
17. Single-dose metyrapone test at 06.00 h: an accurate method for assessment of pituitary-adrenal reserve.
Dickstein G; Lahav M; Orr ZS
Acta Endocrinol (Copenh); 1986 May; 112(1):28-34. PubMed ID: 3716755
[TBL] [Abstract][Full Text] [Related]
18. Metyrapone test with adrenocorticotrophic levels. Separating primary from secondary adrenal insufficiency.
Dolman LI; Nolan G; Jubiz W
JAMA; 1979 Mar; 241(12):1251-3. PubMed ID: 216821
[TBL] [Abstract][Full Text] [Related]
19. Increased pituitary activation following metyrapone administration in post-traumatic stress disorder.
Yehuda R; Levengood RA; Schmeidler J; Wilson S; Guo LS; Gerber D
Psychoneuroendocrinology; 1996 Jan; 21(1):1-16. PubMed ID: 8778898
[TBL] [Abstract][Full Text] [Related]
20. Hypothalamic-pituitary-adrenal axis function in very low birth weight infants treated with dexamethasone.
Alkalay AL; Pomerance JJ; Puri AR; Lin BJ; Vinstein AL; Neufeld ND; Klein AH
Pediatrics; 1990 Aug; 86(2):204-10. PubMed ID: 2371095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
